GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Jolly Pharmaceutical Co Ltd (SZSE:300181) » Definitions » Cyclically Adjusted Revenue per Share

Zhejiang Jolly Pharmaceutical Co (SZSE:300181) Cyclically Adjusted Revenue per Share : ¥2.07 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Zhejiang Jolly Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Zhejiang Jolly Pharmaceutical Co's adjusted revenue per share for the three months ended in Sep. 2024 was ¥0.883. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥2.07 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Zhejiang Jolly Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was 15.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Zhejiang Jolly Pharmaceutical Co was 14.80% per year. The lowest was 14.10% per year. And the median was 14.45% per year.

As of today (2024-12-12), Zhejiang Jolly Pharmaceutical Co's current stock price is ¥16.99. Zhejiang Jolly Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was ¥2.07. Zhejiang Jolly Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 8.21.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Zhejiang Jolly Pharmaceutical Co was 8.84. The lowest was 4.48. And the median was 5.96.


Zhejiang Jolly Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Zhejiang Jolly Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jolly Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Zhejiang Jolly Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.11 1.21 1.41 1.65 1.83

Zhejiang Jolly Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.80 1.83 1.91 1.99 2.07

Competitive Comparison of Zhejiang Jolly Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Zhejiang Jolly Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Jolly Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Jolly Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Jolly Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Zhejiang Jolly Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Jolly Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.883/115.7848*115.7848
=0.883

Current CPI (Sep. 2024) = 115.7848.

Zhejiang Jolly Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.305 99.000 0.357
201503 0.286 99.900 0.331
201506 0.326 99.500 0.379
201509 0.260 100.500 0.300
201512 0.320 100.600 0.368
201603 0.365 102.200 0.414
201606 0.402 101.400 0.459
201609 0.274 102.400 0.310
201612 0.357 102.600 0.403
201703 0.331 103.200 0.371
201706 0.394 103.100 0.442
201709 0.260 104.100 0.289
201712 0.258 104.500 0.286
201803 0.278 105.300 0.306
201806 0.366 104.900 0.404
201809 0.225 106.600 0.244
201812 0.332 106.500 0.361
201903 0.335 107.700 0.360
201906 0.370 107.700 0.398
201909 0.376 109.800 0.396
201912 0.420 111.200 0.437
202003 0.317 112.300 0.327
202006 0.452 110.400 0.474
202009 0.497 111.700 0.515
202012 0.528 111.500 0.548
202103 0.559 112.662 0.574
202106 0.587 111.769 0.608
202109 0.626 112.215 0.646
202112 0.584 113.108 0.598
202203 0.722 114.335 0.731
202206 0.748 114.558 0.756
202209 0.739 115.339 0.742
202212 0.767 115.116 0.771
202303 0.707 115.116 0.711
202306 0.736 114.558 0.744
202309 0.647 115.339 0.650
202312 0.701 114.781 0.707
202403 0.959 115.227 0.964
202406 1.077 114.781 1.086
202409 0.883 115.785 0.883

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Zhejiang Jolly Pharmaceutical Co  (SZSE:300181) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Zhejiang Jolly Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=16.99/2.07
=8.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Zhejiang Jolly Pharmaceutical Co was 8.84. The lowest was 4.48. And the median was 5.96.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Zhejiang Jolly Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Zhejiang Jolly Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Jolly Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No 388 Zhiyuan North Road, Moganshan Economic, Development Zone, Deqing, CHN, 313200
Zhejiang Jolly Pharmaceutical Co Ltd is a China-based company engaged in the production and distribution of pharmaceutical products. Its production lines include raw materials, tablets, capsules, particles and frozen dry powder injection. Its products include Wuling powder, Wuling capsule, linglianhua particle, clindamycin phosphate injection and other.
Executives
Shen Ai Ying Executives
Chen Guo Fen Executives
Yu You Qiang Director
Chen Jian Executives
Zheng Xue Gen Director
Guo Yin Li Supervisors
Wang Tao Executives
Yang Jun De Director
Chen Rui Xiang Supervisors
Dong Hong Yu Directors, executives
Zheng Chao Yi Directors, executives
Zhu Xiao Ping Executives
Wu Ying Securities Affairs Representative

Zhejiang Jolly Pharmaceutical Co Headlines

No Headlines